Abbas Kihame Ismail
Research Interests
Abbas Kihame Ismail has a total of 82 co-authors. Here are the top co-authors by number of shared publications:
- Alexander Kailembo
Division of Global HIV and TB, U.S. Centers for Diseases Control and Prevention, Dar es Salaam, Tanzania
3 shared publications - George Suleman Mgomella
Division of Global HIV and TB, U.S. Centers for Diseases Control and Prevention, Dar es Salaam, Tanzania
3 shared publications - Jerome Kamwela
Tanzania Commission for AIDS, Dodoma, Tanzania
3 shared publications - Wafaa M El Sadr
ICAP at Columbia University, Mailman School of Public Health, New York, New York
3 shared publications Alice Wang
2 shared publications- Andrew C. Voetsch
Division of Global HIV and TB, Global Health Center, Centers for Disease Control and Prevention, USA
2 shared publications
Latest Publications
- 1 July 2026
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 101 (7) , 733-739
Population Viral Load Suppression and Associated Factors in Tanzania: Findings From 2 Sequential Tanzania HIV Impact Surveys of 2016–2017 and 2022–2023
Background: Antiretroviral therapy improves outcomes for people living with HIV (PLHIV) and prevents transmission through viral load suppression (VLS). To evaluate progress toward HIV epidemic control, VLS prevalences and correlates among PLHIV were analyzed from Tanzania HIV Impact Assessment Surveys (THIS), independent, cross-sectional using stratified-cluster design, conducted in 2016–2017 (S1) and 2022–2023 (S2). Methods: Participants 15 years and older provided consent, completed an interviewer-administered questionnaire, and tested for HIV using the national rapid testing algorithm. HIV-positive specimens were tested for viral load. Prevalence of population VLS (P < 0.0001) between surveys. In both surveys, women were more likely to experience VLS [S1: 1.43 (95% CI: 1.25 to 1.63), S2: 1.15 (95% CI: 1.06 to 1.24)] than men. In both surveys, PLHIV 35 years and older were more likely to experience VLS than those 15–24 years, [S1 35–49 years: 1.46 (95% CI: 1.13 to 1.90), 50 years and older: 1.69 (95% CI: 1.28 to 2.23), and S2 35–49 years: 1.31 (95% CI: 1.06 to 1.62), 50 years and older: 1.42 (95% CI: 1.15 to 1.76)]. Conclusion: Tanzania has made progress toward HIV epidemic control, as evidenced by the significant increase in VLS prevalence in 6 years. Targeted sex–age strategies are essential for HIV epidemic control.
- 1 July 2026
- Published by Wolters Kluwer Health in JAIDS Journal of Acquired Immune Deficiency Syndromes
- Vol. 101 (7) , 733-739
Population Viral Load Suppression and Associated Factors in Tanzania: Findings From 2 Sequential Tanzania HIV Impact Surveys of 2016–2017 and 2022–2023
Background: Antiretroviral therapy improves outcomes for people living with HIV (PLHIV) and prevents transmission through viral load suppression (VLS). To evaluate progress toward HIV epidemic control, VLS prevalences and correlates among PLHIV were analyzed from Tanzania HIV Impact Assessment Surveys (THIS), independent, cross-sectional using stratified-cluster design, conducted in 2016–2017 (S1) and 2022–2023 (S2). Methods: Participants 15 years and older provided consent, completed an interviewer-administered questionnaire, and tested for HIV using the national rapid testing algorithm. HIV-positive specimens were tested for viral load. Prevalence of population VLS (P < 0.0001) between surveys. In both surveys, women were more likely to experience VLS [S1: 1.43 (95% CI: 1.25 to 1.63), S2: 1.15 (95% CI: 1.06 to 1.24)] than men. In both surveys, PLHIV 35 years and older were more likely to experience VLS than those 15–24 years, [S1 35–49 years: 1.46 (95% CI: 1.13 to 1.90), 50 years and older: 1.69 (95% CI: 1.28 to 2.23), and S2 35–49 years: 1.31 (95% CI: 1.06 to 1.62), 50 years and older: 1.42 (95% CI: 1.15 to 1.76)]. Conclusion: Tanzania has made progress toward HIV epidemic control, as evidenced by the significant increase in VLS prevalence in 6 years. Targeted sex–age strategies are essential for HIV epidemic control.
- Open Access
- 3 February 2026
- Published by Elsevier in SSRN Electronic Journal
Change in HIV Incidence, Prevalence and Population Viremia in Tanzania: Findings from Tanzania HIV Impact Surveys in 2016–2017 and 2022–2023
Background: Tanzania has over 1.5 million people living with HIV. Understanding changes in its HIV epidemic is critical to informing interventions and policies. We aim to describe the state of Tanzania’s HIV epidemic and progress towards epidemic control by evaluating changes in population-level HIV prevalence, HIV incidence, and viremia between 2016–2017 and 2022–2023. Methods: Sequential Tanzania HIV Impact Surveys (THIS) 2016–2017 and 2022–2023 were nationally-representative, cross-sectional household-based surveys with a stratified, two-stage cluster design. Participants aged ≥15 years provided information on HIV testing and treatment histories and blood samples for HIV serology. HIV incidence was estimated using a laboratory-based algorithm (HIV-1 Limiting Antigen (Lag) avidity, viral load (VL), and antiretroviral (ARV) detection). We calculated weighted estimates of population-level HIV prevalence, HIV incidence, and viremia and compared them between surveys. Arithmetic differences and incidence rate ratios were used to assess change. Modified Poisson regression models were used to estimate adjusted prevalence ratios (aPR) for correlates of HIV prevalence and viremia. Findings: Among participants aged ≥15 years with biomarker data (n=31,579 in 2016–2017; n=33,663 in 2022–2023), 1,831 and 1,850 were living with HIV, respectively. HIV prevalence remained stable at 4.9% [95% CI: 4.5–5.2] in 2016–2017 and 4.4% [4.1–4.7] in 2022–2023. Annual HIV incidence did not significantly change (0.24% [0.15–0.34] vs. 0.18% [0.09–0.26]). Population viremia declined significantly from 2.8% [2.6–3.1] to 1.7% [1.5–1.8], with a 41% reduction between surveys (aPR: 0.59 [0.52–0.67]). Higher prevalence and viremia were observed among women and adults aged ≥25 years. Interpretation: Between 2016–2017 and 2022–2023, HIV prevalence and incidence remained stable in Tanzania, while population viremia declined substantially, indicating progress towards HIV epidemic control. Continued efforts and targeted interventions are needed to reduce viremia among women and older age groups.
- 3 February 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessChange in HIV Incidence, Prevalence and Population Viremia in Tanzania: Findings from Tanzania HIV Impact Surveys in 2016–2017 and 2022–2023
Background: Tanzania has over 1.5 million people living with HIV. Understanding changes in its HIV epidemic is critical to informing interventions and policies. We aim to describe the state of Tanzania’s HIV epidemic and progress towards epidemic control by evaluating changes in population-level HIV prevalence, HIV incidence, and viremia between 2016–2017 and 2022–2023. Methods: Sequential Tanzania HIV Impact Surveys (THIS) 2016–2017 and 2022–2023 were nationally-representative, cross-sectional household-based surveys with a stratified, two-stage cluster design. Participants aged ≥15 years provided information on HIV testing and treatment histories and blood samples for HIV serology. HIV incidence was estimated using a laboratory-based algorithm (HIV-1 Limiting Antigen (Lag) avidity, viral load (VL), and antiretroviral (ARV) detection). We calculated weighted estimates of population-level HIV prevalence, HIV incidence, and viremia and compared them between surveys. Arithmetic differences and incidence rate ratios were used to assess change. Modified Poisson regression models were used to estimate adjusted prevalence ratios (aPR) for correlates of HIV prevalence and viremia. Findings: Among participants aged ≥15 years with biomarker data (n=31,579 in 2016–2017; n=33,663 in 2022–2023), 1,831 and 1,850 were living with HIV, respectively. HIV prevalence remained stable at 4.9% [95% CI: 4.5–5.2] in 2016–2017 and 4.4% [4.1–4.7] in 2022–2023. Annual HIV incidence did not significantly change (0.24% [0.15–0.34] vs. 0.18% [0.09–0.26]). Population viremia declined significantly from 2.8% [2.6–3.1] to 1.7% [1.5–1.8], with a 41% reduction between surveys (aPR: 0.59 [0.52–0.67]). Higher prevalence and viremia were observed among women and adults aged ≥25 years. Interpretation: Between 2016–2017 and 2022–2023, HIV prevalence and incidence remained stable in Tanzania, while population viremia declined substantially, indicating progress towards HIV epidemic control. Continued efforts and targeted interventions are needed to reduce viremia among women and older age groups.
- Open Access
- 3 February 2026
- Published by Elsevier in SSRN Electronic Journal
Progress Towards Global 95–95–95 Targets in Tanzania: Trends from Tanzania HIV Impact Surveys in 2016–2017 and 2022–2023
Background: The global 95–95–95 targets state that 95% of people living with HIV (PLHIV) are aware of their HIV status, 95% of those are taking antiretroviral therapy (ART), and 95% of those have HIV viral load (VL) suppression (VLS). We evaluated change in 95–95–95 achievement between two rounds of a national HIV survey in Tanzania. Methods: The Tanzania HIV Impact Surveys (THIS) in 2016–2017 and 2022–2023 were nationally-representative, cross-sectional household surveys. Consenting participants responded to a questionnaire and provided blood specimens for biomarker testing. We reported 95–95–95 achievement among PLHIV aged ≥15 years in each round and the change using prevalence differences. We determined awareness of status and ART use through both self-report and detection of ARVs in the blood. We defined HIV VLS as HIV VL <1,000 copies/mL. Analyses accounted for the complex survey design with pooled survey weights and Jackknife variance estimation. Findings: This analysis included 1,831 and 1,850 PLHIV aged ≥15 years from THIS 2016–2017 and THIS 2022–2023, respectively. PLHIV aware of HIV-positive status increased from 61.0% [57.1–63.9] in 2017 to 83.0% [80.0–85.1] in 2023; this was a prevalence difference of 22.1% [17.8–26.3]. Among PLHIV aware of their status, ART coverage increased from 93.6% [91.7–95.2] in 2017 to 97.9% [96.7–98.6] in 2023; this was a prevalence difference of 4.2% [2.3–6.2]. Among PLHIV on ART, the percent with VLS increased from 87.0% [84.1–89.5] in 2017 to 94.3% [92.6–95.6] in 2023; this was a prevalence difference of 7.2% [4.2–10.3]. Interpretation: Tanzania made remarkable progress towards all three 95–95–95 targets in the five years between surveys. Efforts are needed to enhance case identification through tailored strategies.
- 3 February 2026
- Published by Elsevier in SSRN Electronic Journal
Open AccessProgress Towards Global 95–95–95 Targets in Tanzania: Trends from Tanzania HIV Impact Surveys in 2016–2017 and 2022–2023
Background: The global 95–95–95 targets state that 95% of people living with HIV (PLHIV) are aware of their HIV status, 95% of those are taking antiretroviral therapy (ART), and 95% of those have HIV viral load (VL) suppression (VLS). We evaluated change in 95–95–95 achievement between two rounds of a national HIV survey in Tanzania. Methods: The Tanzania HIV Impact Surveys (THIS) in 2016–2017 and 2022–2023 were nationally-representative, cross-sectional household surveys. Consenting participants responded to a questionnaire and provided blood specimens for biomarker testing. We reported 95–95–95 achievement among PLHIV aged ≥15 years in each round and the change using prevalence differences. We determined awareness of status and ART use through both self-report and detection of ARVs in the blood. We defined HIV VLS as HIV VL <1,000 copies/mL. Analyses accounted for the complex survey design with pooled survey weights and Jackknife variance estimation. Findings: This analysis included 1,831 and 1,850 PLHIV aged ≥15 years from THIS 2016–2017 and THIS 2022–2023, respectively. PLHIV aware of HIV-positive status increased from 61.0% [57.1–63.9] in 2017 to 83.0% [80.0–85.1] in 2023; this was a prevalence difference of 22.1% [17.8–26.3]. Among PLHIV aware of their status, ART coverage increased from 93.6% [91.7–95.2] in 2017 to 97.9% [96.7–98.6] in 2023; this was a prevalence difference of 4.2% [2.3–6.2]. Among PLHIV on ART, the percent with VLS increased from 87.0% [84.1–89.5] in 2017 to 94.3% [92.6–95.6] in 2023; this was a prevalence difference of 7.2% [4.2–10.3]. Interpretation: Tanzania made remarkable progress towards all three 95–95–95 targets in the five years between surveys. Efforts are needed to enhance case identification through tailored strategies.
- Open Access
- 1 January 2025
- Published by Wiley in Journal of Probability and Statistics
- Vol. 2025 (1)
Regression Modeling Using Generalized Pareto‐IV Distribution With Application to Household Budget Survey
The study introduced the new regression model by the T‐X family technique of Type I half‐logistic and Pareto IV distribution (TIHLPIV) that had to solve the weaknesses of mixed methods, which are limited to applicability, data requirements, and computational complexity. Data transformation was needed for generalization (G‐family) of combined distributions, and the T‐X technique allowed flexibility, risk assessment, environmental studies, quality control, and scientific research in modeling different kinds of data and covering a wider range of real‐life applications such as survival and lifetime data, hydrology, economics (income inequality), and engineering. The general objective of the study was to introduce new regression modeling using generalized Pareto IV distribution (TIHLPIV) with application to the Household Budget Survey (HBS) for the years 2017‐18 on the Tanzania Mainland. According to empirical results, it is revealed that the proposed model gives better results than other existing models.
- 1 January 2025
- Published by Wiley in Journal of Probability and Statistics
- Vol. 2025 (1)
Open AccessRegression Modeling Using Generalized Pareto‐IV Distribution With Application to Household Budget Survey
The study introduced the new regression model by the T‐X family technique of Type I half‐logistic and Pareto IV distribution (TIHLPIV) that had to solve the weaknesses of mixed methods, which are limited to applicability, data requirements, and computational complexity. Data transformation was needed for generalization (G‐family) of combined distributions, and the T‐X technique allowed flexibility, risk assessment, environmental studies, quality control, and scientific research in modeling different kinds of data and covering a wider range of real‐life applications such as survival and lifetime data, hydrology, economics (income inequality), and engineering. The general objective of the study was to introduce new regression modeling using generalized Pareto IV distribution (TIHLPIV) with application to the Household Budget Survey (HBS) for the years 2017‐18 on the Tanzania Mainland. According to empirical results, it is revealed that the proposed model gives better results than other existing models.
- Open Access
- 18 December 2023
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 139, 176-182
Trends of measles in Tanzania: A 5-year review of case-based surveillance data, 2018-2022
- 18 December 2023
- Published by Elsevier in International Journal of Infectious Diseases
- Vol. 139, 176-182
Open AccessTrends of measles in Tanzania: A 5-year review of case-based surveillance data, 2018-2022